SENNOSIDES A AND B

SENNOSIDES A AND B was reported 1644 times

SENNOSIDES A AND B is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREVIBACTERIUM INFECTION 1 0.1111
1 PULMONARY VASCULITIS 37 0.0688
2 SOFT TISSUE MASS 26 0.0563
3 BULBOSPINAL MUSCULAR ATROPHY CONGENITAL 2 0.0465
4 CARDIOSPASM 25 0.0448
5 TOTAL LUNG CAPACITY ABNORMAL 16 0.0411
6 CAPILLARITIS 11 0.0399
7 IMMUNISATION 15 0.0346
8 PALMOPLANTAR KERATODERMA 25 0.0345
9 SEPTIC RASH 2 0.0333
10 OESOPHAGEAL PERFORATION 27 0.0324
11 PANCREATOGENOUS DIABETES 2 0.0308
12 SPIROMETRY ABNORMAL 16 0.0268
13 MITE ALLERGY 17 0.0260
14 NEURITIS 38 0.0246
15 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 16 0.0218
16 MULTIMORBIDITY 26 0.0217
17 TEMPERATURE REGULATION DISORDER 46 0.0206
18 MYCOTIC ALLERGY 17 0.0199
19 ANAL EROSION 2 0.0182
20 DUST ALLERGY 17 0.0173
21 SUPERINFECTION 26 0.0173
22 PARANEOPLASTIC NEUROLOGICAL SYNDROME 2 0.0156
23 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 27 0.0132
24 RESPIRATORY SYMPTOM 37 0.0130
25 CARDIAC CONTRACTILITY DECREASED 1 0.0130
26 BURSA REMOVAL 1 0.0125
27 ATRIAL TACHYCARDIA 26 0.0124
28 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
29 CONJUNCTIVITIS ALLERGIC 17 0.0115
30 CREATININE RENAL CLEARANCE INCREASED 8 0.0107
31 PRURITUS GENITAL 25 0.0106
32 TRANSPLANT FAILURE 26 0.0106
33 LUNG CONSOLIDATION 27 0.0096
34 FOETAL DEATH 49 0.0094
35 ADJUSTED CALCIUM DECREASED 1 0.0094
36 MULTIPLE DRUG THERAPY 7 0.0093
37 KL-6 INCREASED 2 0.0088
38 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 27 0.0082
39 LIPID METABOLISM DISORDER 3 0.0078
40 AORTIC SURGERY 1 0.0076
41 CHOLANGITIS INFECTIVE 2 0.0075
42 PULMONARY ALVEOLAR HAEMORRHAGE 40 0.0071
43 CAROTID ARTERY OCCLUSION 26 0.0071
44 VITAMIN B1 DEFICIENCY 3 0.0070
45 NEUROLOGICAL SYMPTOM 40 0.0070
46 FOOD ALLERGY 54 0.0070
47 POSITIVE AIRWAY PRESSURE THERAPY 2 0.0068
48 ASPERGILLUS TEST POSITIVE 2 0.0065
49 BILIARY TRACT INFECTION 4 0.0064
50 TENSION HEADACHE 26 0.0060
51 FORCED EXPIRATORY VOLUME DECREASED 17 0.0060
52 DEFAECATION DISORDER 4 0.0060
53 SLEEP TERROR 25 0.0059
54 APPLICATION SITE INDURATION 1 0.0059
55 CARNITINE DEFICIENCY 1 0.0058
56 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
57 IMMUNE-MEDIATED ENCEPHALITIS 3 0.0057
58 NORMOCHROMIC NORMOCYTIC ANAEMIA 17 0.0057
59 INFLAMMATORY MARKER INCREASED 28 0.0056
60 VASCULITIS 63 0.0054
61 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 5 0.0054
62 BLOOD INSULIN ABNORMAL 1 0.0053
63 APPLICATION SITE INJURY 1 0.0053
64 STOMA SITE EXTRAVASATION 2 0.0052
65 RALES 30 0.0052
66 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
67 PNEUMOCOCCAL INFECTION 3 0.0051
68 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
69 ADENOCARCINOMA METASTATIC 1 0.0049
70 IMMUNE-MEDIATED RENAL DISORDER 2 0.0048
71 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
72 OTITIS MEDIA CHRONIC 2 0.0048
73 ADULT FAILURE TO THRIVE 1 0.0047
74 TRANSFERRIN SATURATION DECREASED 2 0.0047
75 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
76 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 3 0.0045
77 SEDATION COMPLICATION 11 0.0043
78 ECZEMA ASTEATOTIC 2 0.0042
79 CARCINOID TUMOUR PULMONARY 1 0.0041
80 OBSTRUCTIVE AIRWAYS DISORDER 43 0.0039
81 OCCULT BLOOD 2 0.0038
82 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 3 0.0038
83 IMMUNODEFICIENCY 54 0.0036
84 COELIAC DISEASE 35 0.0036
85 ASBESTOSIS 1 0.0035
86 AVERSION 1 0.0035
87 BLOOD CORTICOTROPHIN INCREASED 1 0.0035
88 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
89 THALAMIC INFARCTION 2 0.0034
90 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
91 FULL BLOOD COUNT ABNORMAL 34 0.0032
92 STOMA SITE HYPERGRANULATION 2 0.0032
93 BREAST CELLULITIS 1 0.0032
94 BACILLUS INFECTION 2 0.0032
95 BACTERIAL TRANSLOCATION 1 0.0032
96 ANKLE DEFORMITY 1 0.0031
97 ACANTHOSIS 1 0.0030
98 ENCEPHALITIS AUTOIMMUNE 4 0.0030
99 ARTERIOSCLEROSIS CORONARY ARTERY 20 0.0030
100 HEPATITIS B DNA INCREASED 2 0.0030
101 BURSITIS 36 0.0030
102 ALCOHOLIC LIVER DISEASE 1 0.0029
103 FULMINANT TYPE 1 DIABETES MELLITUS 3 0.0029
104 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
105 PNEUMONIA VIRAL 9 0.0028
106 FACIAL PAIN 25 0.0028
107 CREATININE RENAL CLEARANCE DECREASED 11 0.0027
108 PRESCRIBED OVERDOSE 53 0.0027
109 ENDOMETRIAL CANCER 6 0.0027
110 SUBARACHNOID HAEMORRHAGE 27 0.0026
111 HAEMOPTYSIS 71 0.0025
112 PRODUCT CONFUSION 2 0.0025
113 TOTAL LUNG CAPACITY DECREASED 4 0.0025
114 MYOCARDIAL ISCHAEMIA 28 0.0025
115 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
116 GIANT CELL ARTERITIS 2 0.0024
117 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 21 0.0024
118 CARDIOMEGALY 29 0.0024
119 PULMONARY FIBROSIS 45 0.0023
120 URGE INCONTINENCE 2 0.0023
121 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
122 LUNG OPACITY 6 0.0023
123 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
124 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
125 INTESTINAL INFARCTION 2 0.0022
126 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
127 BIOPSY BONE MARROW 1 0.0021
128 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
129 KLEBSIELLA BACTERAEMIA 2 0.0021
130 BLOOD URIC ACID DECREASED 1 0.0021
131 SPUTUM RETENTION 2 0.0020
132 PNEUMONIA ASPIRATION 50 0.0020
133 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
134 RENAL FUNCTION TEST ABNORMAL 9 0.0019
135 VENTRICULAR TACHYCARDIA 32 0.0019
136 ABDOMINAL INJURY 1 0.0019
137 TUMOUR NECROSIS 2 0.0019
138 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
139 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
140 COMPRESSION FRACTURE 10 0.0019
141 JOINT CONTRACTURE 2 0.0019
142 TUMOUR PSEUDOPROGRESSION 2 0.0018
143 CARDIAC AMYLOIDOSIS 2 0.0018
144 ARTERIOSCLEROSIS 17 0.0018
145 ANOSMIA 26 0.0018
146 IMMUNE-MEDIATED LUNG DISEASE 3 0.0016
147 DRUG LEVEL INCREASED 27 0.0016
148 OESOPHAGEAL SPASM 3 0.0016
149 BLOOD BILIRUBIN DECREASED 1 0.0016
150 RENAL ATROPHY 2 0.0016
151 BLOOD OSMOLARITY DECREASED 1 0.0016
152 SMALL INTESTINAL PERFORATION 3 0.0016
153 ARTERITIS 1 0.0016
154 TROPONIN T INCREASED 2 0.0016
155 FEMORAL NECK FRACTURE 8 0.0016
156 PHYSICAL DECONDITIONING 4 0.0016
157 AUTOIMMUNE COLITIS 1 0.0016
158 PERICARDITIS 26 0.0015
159 SLOW RESPONSE TO STIMULI 2 0.0015
160 DECREASED IMMUNE RESPONSIVENESS 15 0.0015
161 BONE OPERATION 1 0.0015
162 BRONCHITIS VIRAL 1 0.0015
163 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
164 NEUROMYELITIS OPTICA SPECTRUM DISORDER 2 0.0015
165 ABSCESS NECK 1 0.0015
166 CALCULUS BLADDER 2 0.0015
167 EFFUSION 2 0.0015
168 CHOLANGITIS SCLEROSING 3 0.0015
169 AORTITIS 1 0.0015
170 RADIATION PNEUMONITIS 3 0.0014
171 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
172 ANTIBODY TEST ABNORMAL 1 0.0014
173 NODULE 18 0.0014
174 BACTERIAL DISEASE CARRIER 1 0.0014
175 PNEUMONIA PNEUMOCOCCAL 2 0.0013
176 BLISTER RUPTURE 1 0.0013
177 GASTROINTESTINAL WALL THICKENING 2 0.0013
178 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
179 STEROID DIABETES 2 0.0013
180 SPINAL COMPRESSION FRACTURE 11 0.0013
181 SUSPECTED OFF LABEL USE 6 0.0013
182 BODY TEMPERATURE DECREASED 13 0.0013
183 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
184 LIVER ABSCESS 4 0.0012
185 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
186 ENTEROCOLITIS 7 0.0012
187 SEBORRHOEIC DERMATITIS 2 0.0012
188 CAMPYLOBACTER INFECTION 1 0.0012
189 VEIN RUPTURE 2 0.0012
190 PRODUCTIVE COUGH 57 0.0012
191 ASCITES 35 0.0012
192 HYPOTHYROIDISM 38 0.0012
193 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
194 ATONIC SEIZURES 1 0.0012
195 INFUSION RELATED REACTION 77 0.0012
196 FEBRILE NEUTROPENIA 77 0.0012
197 LIPOMA 3 0.0012
198 HYPOPITUITARISM 2 0.0011
199 VASCULAR PSEUDOANEURYSM 2 0.0011
200 DEPRESSIVE SYMPTOM 4 0.0011
201 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
202 MUSCLE TWITCHING 26 0.0011
203 AORTIC VALVE STENOSIS 2 0.0011
204 ILEUS PARALYTIC 5 0.0011
205 NEUTROPENIC SEPSIS 8 0.0011
206 UPPER RESPIRATORY TRACT INFECTION 51 0.0011
207 ARTERIOVENOUS MALFORMATION 1 0.0011
208 CEREBRAL VENOUS THROMBOSIS 2 0.0011
209 CYTOKINE RELEASE SYNDROME 22 0.0011
210 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
211 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
212 ADENOCARCINOMA GASTRIC 1 0.0011
213 PROCTITIS 3 0.0011
214 BRAIN STEM HAEMORRHAGE 1 0.0011
215 CANCER SURGERY 1 0.0010
216 DIPLOPIA 27 0.0010
217 CLEFT PALATE 2 0.0010
218 BLADDER CATHETERISATION 1 0.0010
219 APPLICATION SITE BRUISE 1 0.0010
220 PYELONEPHRITIS ACUTE 2 0.0010
221 BREATH SOUNDS ABNORMAL 5 0.0010
222 CARDIAC ANEURYSM 1 0.0010
223 RASH ERYTHEMATOUS 48 0.0010
224 OESOPHAGEAL CANDIDIASIS 4 0.0010
225 FLUID RETENTION 51 0.0010
226 ACQUIRED HAEMOPHILIA 1 0.0010
227 HYPOPHYSITIS 2 0.0010
228 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
229 PULMONARY TOXICITY 7 0.0010
230 DYSCHEZIA 3 0.0010
231 EXPOSURE DURING PREGNANCY 61 0.0010
232 BREAST ABSCESS 1 0.0010
233 IMMUNE-MEDIATED HEPATITIS 2 0.0010
234 CHOLANGITIS 6 0.0010
235 GASTROINTESTINAL PERFORATION 4 0.0010
236 ONYCHOMADESIS 4 0.0010
237 NON-CARDIAC CHEST PAIN 3 0.0009
238 POLYMYALGIA RHEUMATICA 3 0.0009
239 RENAL NEOPLASM 2 0.0009
240 CARDIAC FAILURE CHRONIC 4 0.0009
241 PAIN OF SKIN 25 0.0009
242 ASPIRATION 10 0.0009
243 OESOPHAGEAL CARCINOMA 27 0.0009
244 CLOSTRIDIUM TEST POSITIVE 2 0.0009
245 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
246 INTENTIONAL PRODUCT MISUSE 79 0.0009
247 AORTIC DILATATION 1 0.0009
248 LARGE INTESTINAL OBSTRUCTION 2 0.0009
249 ADENOCARCINOMA 2 0.0009
250 COLITIS ISCHAEMIC 6 0.0009
251 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
252 CHRONIC GASTRITIS 2 0.0009
253 HYPOXIA 31 0.0009
254 COGNITIVE DISORDER 41 0.0009
255 WHEEZING 52 0.0009
256 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
257 ONYCHOCLASIS 6 0.0009
258 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
259 PLEURAL EFFUSION 53 0.0009
260 CARBON DIOXIDE DECREASED 1 0.0009
261 IRON DEFICIENCY ANAEMIA 8 0.0009
262 HEPATIC ENZYME INCREASED 59 0.0009
263 EMBOLIC STROKE 3 0.0009
264 COVID-19 PNEUMONIA 10 0.0008
265 INTERSTITIAL LUNG DISEASE 41 0.0008
266 VOLVULUS 2 0.0008
267 PUSTULE 2 0.0008
268 LIP SWELLING 28 0.0008
269 BILE DUCT STENOSIS 1 0.0008
270 BLEEDING TIME PROLONGED 1 0.0008
271 FINGER DEFORMITY 4 0.0008
272 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
273 DENTAL CARIES 9 0.0008
274 LOWER RESPIRATORY TRACT INFECTION 37 0.0008
275 HYPERVOLAEMIA 4 0.0008
276 ORTHOSTATIC HYPOTENSION 14 0.0008
277 EYE PRURITUS 27 0.0008
278 BLOOD CALCIUM DECREASED 9 0.0008
279 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
280 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
281 LUNG DISORDER 39 0.0008
282 PEMPHIGOID 6 0.0008
283 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
284 CATHETER SITE INFECTION 3 0.0008
285 BRONCHIAL SECRETION RETENTION 1 0.0008
286 DISSEMINATED TUBERCULOSIS 2 0.0008
287 ASTHMA 88 0.0008
288 AORTIC ARTERIOSCLEROSIS 2 0.0008
289 BILIARY OBSTRUCTION 1 0.0008
290 HYPOALBUMINAEMIA 6 0.0008
291 APLASTIC ANAEMIA 4 0.0008
292 TORSADE DE POINTES 6 0.0008
293 HYPOGLYCAEMIA 37 0.0008
294 PNEUMONIA FUNGAL 3 0.0008
295 OESOPHAGEAL PAIN 3 0.0008
296 CARDIAC FAILURE ACUTE 5 0.0007
297 ANIMAL BITE 2 0.0007
298 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
299 CYSTITIS HAEMORRHAGIC 3 0.0007
300 BLOOD SODIUM INCREASED 2 0.0007
301 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
302 STOMA SITE DISCHARGE 2 0.0007
303 HYPERURICAEMIA 3 0.0007
304 IMMUNE-MEDIATED MYOSITIS 2 0.0007
305 PLEURITIC PAIN 2 0.0007
306 ON AND OFF PHENOMENON 4 0.0007
307 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
308 PSYCHOMOTOR RETARDATION 2 0.0007
309 BLINDNESS 29 0.0007
310 TUMOUR HAEMORRHAGE 2 0.0007
311 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
312 HYPERTONIC BLADDER 2 0.0007
313 HYPERHIDROSIS 89 0.0007
314 DYSPNOEA AT REST 2 0.0007
315 STRIDOR 2 0.0007
316 THYROIDITIS 2 0.0007
317 CONSTIPATION 145 0.0007
318 ASTIGMATISM 1 0.0007
319 ADRENAL INSUFFICIENCY 8 0.0007
320 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
321 DERMATITIS ACNEIFORM 4 0.0007
322 RETCHING 14 0.0007
323 RECTAL CANCER 2 0.0007
324 HEPATIC FUNCTION ABNORMAL 24 0.0006
325 PERFORMANCE STATUS DECREASED 3 0.0006
326 YELLOW SKIN 3 0.0006
327 BLOOD CREATININE DECREASED 2 0.0006
328 HALLUCINATION 48 0.0006
329 SKIN ABRASION 3 0.0006
330 INFUSION SITE PRURITUS 2 0.0006
331 SPUTUM DISCOLOURED 6 0.0006
332 TINNITUS 29 0.0006
333 RENAL IMPAIRMENT 53 0.0006
334 HEPATITIS B REACTIVATION 2 0.0006
335 BILE DUCT STONE 2 0.0006
336 ANTICHOLINERGIC SYNDROME 1 0.0006
337 SKIN EROSION 2 0.0006
338 PORTAL VEIN THROMBOSIS 2 0.0006
339 NEUTROPHIL COUNT DECREASED 25 0.0006
340 ANGIOEDEMA 27 0.0006
341 BLADDER DISORDER 6 0.0006
342 HYPERNATRAEMIA 3 0.0006
343 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
344 BRONCHIECTASIS 4 0.0006
345 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
346 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
347 NEOPLASM RECURRENCE 2 0.0006
348 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
349 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
350 ENCEPHALITIS 4 0.0006
351 CARDIAC MURMUR 5 0.0006
352 LARGE INTESTINE PERFORATION 4 0.0006
353 CATATONIA 3 0.0006
354 BLOOD CALCIUM INCREASED 5 0.0006
355 TUMOUR LYSIS SYNDROME 5 0.0006
356 TREATMENT FAILURE 47 0.0006
357 COMA 27 0.0006
358 GLOSSITIS 2 0.0006
359 HAEMORRHAGIC DIATHESIS 2 0.0006
360 SUBDURAL HAEMATOMA 8 0.0006
361 THROMBOCYTOPENIA 62 0.0006
362 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
363 FAECES SOFT 4 0.0005
364 HYPERKERATOSIS 3 0.0005
365 PYREXIA 188 0.0005
366 WOUND HAEMORRHAGE 2 0.0005
367 CARDIAC DYSFUNCTION 2 0.0005
368 ERYTHEMA MULTIFORME 5 0.0005
369 SKIN INFECTION 6 0.0005
370 COLITIS 20 0.0005
371 TROPONIN INCREASED 4 0.0005
372 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
373 DISTURBANCE IN ATTENTION 28 0.0005
374 HAEMOLYSIS 4 0.0005
375 DRUG INTOLERANCE 50 0.0005
376 STRESS CARDIOMYOPATHY 3 0.0005
377 EOSINOPHILIA 9 0.0005
378 VENOUS THROMBOSIS 2 0.0005
379 PROSTATOMEGALY 2 0.0005
380 POLYDIPSIA 2 0.0005
381 DYSPHAGIA 48 0.0005
382 BLOOD IRON DECREASED 6 0.0005
383 BACTERAEMIA 6 0.0005
384 FURUNCLE 4 0.0005
385 CHOLECYSTITIS 6 0.0005
386 HYPERPHAGIA 2 0.0005
387 BLOOD DISORDER 4 0.0005
388 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
389 STOMATITIS 30 0.0005
390 HYPOTHERMIA 5 0.0005
391 POLYURIA 4 0.0005
392 HYPERCALCAEMIA 6 0.0005
393 GENERALISED OEDEMA 6 0.0005
394 ILEUS 6 0.0005
395 JOINT SWELLING 58 0.0005
396 BODY TEMPERATURE FLUCTUATION 1 0.0005
397 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
398 AORTIC VALVE INCOMPETENCE 2 0.0005
399 PULMONARY MASS 7 0.0005
400 ABSCESS LIMB 2 0.0005
401 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
402 PYELONEPHRITIS 4 0.0005
403 HYPONATRAEMIA 26 0.0005
404 AMNESIA 30 0.0005
405 MONOPLEGIA 2 0.0005
406 BRADYPHRENIA 3 0.0005
407 HYPOKALAEMIA 21 0.0005
408 CORONAVIRUS INFECTION 3 0.0005
409 LYMPHOCYTE COUNT DECREASED 8 0.0005
410 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
411 BACTERIAL TEST POSITIVE 1 0.0004
412 SEPSIS 50 0.0004
413 HAEMOGLOBIN INCREASED 2 0.0004
414 DERMATITIS CONTACT 5 0.0004
415 PNEUMONIA BACTERIAL 4 0.0004
416 LYMPHOEDEMA 3 0.0004
417 UROSEPSIS 4 0.0004
418 SYNOVIAL CYST 2 0.0004
419 NEPHROGENIC ANAEMIA 2 0.0004
420 RIGHT VENTRICULAR FAILURE 3 0.0004
421 UNDERDOSE 31 0.0004
422 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
423 MUSCULAR WEAKNESS 46 0.0004
424 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
425 MUCOUS STOOLS 2 0.0004
426 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
427 ORGANISING PNEUMONIA 2 0.0004
428 HYPERAMMONAEMIA 2 0.0004
429 CARDIAC FAILURE CONGESTIVE 32 0.0004
430 HEART RATE IRREGULAR 9 0.0004
431 CELLULITIS 20 0.0004
432 RHEUMATOID ARTHRITIS 45 0.0004
433 BACK PAIN 92 0.0004
434 TOXIC ENCEPHALOPATHY 2 0.0004
435 DYSLIPIDAEMIA 2 0.0004
436 BOWEL MOVEMENT IRREGULARITY 3 0.0004
437 CANCER PAIN 1 0.0004
438 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
439 BLOOD CHLORIDE DECREASED 1 0.0004
440 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
441 POOR VENOUS ACCESS 4 0.0004
442 INJECTION SITE INDURATION 5 0.0004
443 FAILURE TO THRIVE 2 0.0004
444 SEDATION 10 0.0004
445 PNEUMOTHORAX 6 0.0004
446 DEHYDRATION 50 0.0004
447 ANAL FISSURE 2 0.0004
448 TACHYCARDIA 33 0.0004
449 ANAL ABSCESS 2 0.0004
450 GINGIVITIS 2 0.0004
451 SKIN LACERATION 4 0.0004
452 PSORIASIS 48 0.0004
453 BLOOD PHOSPHORUS INCREASED 1 0.0004
454 ABNORMAL FAECES 3 0.0004
455 ASTHENOPIA 2 0.0004
456 CYTOMEGALOVIRUS INFECTION 6 0.0004
457 SECOND PRIMARY MALIGNANCY 3 0.0004
458 COVID-19 63 0.0004
459 HYPERTENSION 76 0.0004
460 MALNUTRITION 4 0.0004
461 ANAL HAEMORRHAGE 1 0.0004
462 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
463 BREAST CANCER STAGE IV 1 0.0004
464 BLOOD MAGNESIUM DECREASED 3 0.0003
465 PLATELET COUNT DECREASED 37 0.0003
466 DELIRIUM 12 0.0003
467 MYELODYSPLASTIC SYNDROME 5 0.0003
468 ADENOVIRUS INFECTION 1 0.0003
469 DECREASED APPETITE 80 0.0003
470 ELECTROLYTE IMBALANCE 4 0.0003
471 NEUROTOXICITY 6 0.0003
472 LEUKOPENIA 17 0.0003
473 ACUTE KIDNEY INJURY 52 0.0003
474 PURPURA 3 0.0003
475 BRADYKINESIA 2 0.0003
476 PULMONARY EMBOLISM 32 0.0003
477 DRUG ABUSE 28 0.0003
478 THIRST 6 0.0003
479 PRODUCT USE ISSUE 63 0.0003
480 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
481 PLATELET COUNT ABNORMAL 2 0.0003
482 URINARY RETENTION 11 0.0003
483 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
484 LIVER FUNCTION TEST INCREASED 7 0.0003
485 MIGRAINE 31 0.0003
486 OVERDOSE 70 0.0003
487 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
488 CARDIAC FAILURE 26 0.0003
489 DEMENTIA 9 0.0003
490 PEMPHIGUS 4 0.0003
491 SPINAL DISORDER 3 0.0003
492 GASTRIC ULCER 6 0.0003
493 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
494 TRANSAMINASES INCREASED 7 0.0003
495 CYSTITIS 10 0.0003
496 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
497 ENTERITIS 2 0.0003
498 HYPERSENSITIVITY 58 0.0003
499 ACUTE RESPIRATORY FAILURE 6 0.0003
500 ERYTHEMA 64 0.0003
501 PROCTALGIA 2 0.0003
502 DRUG INTERACTION 49 0.0003
503 HAEMORRHOIDS 6 0.0003
504 ACUTE MYOCARDIAL INFARCTION 9 0.0003
505 CHOLELITHIASIS 10 0.0003
506 METASTASES TO BONE 5 0.0003
507 SARS-COV-2 TEST POSITIVE 4 0.0003
508 PNEUMONIA 98 0.0003
509 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
510 RASH 131 0.0003
511 BRAIN INJURY 3 0.0003
512 SWELLING 28 0.0003
513 SEPTIC SHOCK 13 0.0003
514 BLOOD UREA INCREASED 5 0.0003
515 HERPES ZOSTER 17 0.0003
516 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
517 HEART RATE INCREASED 29 0.0003
518 EYE MOVEMENT DISORDER 2 0.0003
519 NEPHROTIC SYNDROME 2 0.0003
520 SKIN LESION 8 0.0003
521 BLOOD PRESSURE FLUCTUATION 7 0.0003
522 BLOOD CREATININE INCREASED 19 0.0003
523 APLASIA PURE RED CELL 1 0.0003
524 RESPIRATORY DISTRESS 8 0.0003
525 ANAEMIA 55 0.0003
526 PRESYNCOPE 7 0.0003
527 CEREBRAL INFARCTION 7 0.0003
528 TRANSFUSION 3 0.0003
529 BLOOD TEST ABNORMAL 4 0.0003
530 HALLUCINATION, VISUAL 6 0.0003
531 DUODENAL ULCER 2 0.0003
532 DRUG ERUPTION 5 0.0003
533 THERMAL BURN 2 0.0003
534 MYELOSUPPRESSION 10 0.0003
535 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
536 HYPERTHYROIDISM 4 0.0003
537 C-REACTIVE PROTEIN INCREASED 10 0.0003
538 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
539 HYPOPHAGIA 7 0.0003
540 PSYCHIATRIC SYMPTOM 2 0.0003
541 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
542 VIRAL INFECTION 9 0.0003
543 VENTRICULAR FIBRILLATION 3 0.0003
544 STEVENS-JOHNSON SYNDROME 6 0.0003
545 COLON CANCER 4 0.0003
546 SUNBURN 2 0.0003
547 HEPATIC CIRRHOSIS 5 0.0003
548 HYPOCALCAEMIA 5 0.0003
549 HEPATOCELLULAR CARCINOMA 2 0.0003
550 AORTIC ANEURYSM 2 0.0003
551 SLEEP APNOEA SYNDROME 5 0.0003
552 PERICARDIAL EFFUSION 6 0.0003
553 ANKLE FRACTURE 4 0.0003
554 DYSPNOEA 146 0.0003
555 APHTHOUS ULCER 2 0.0003
556 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
557 PNEUMONITIS 7 0.0003
558 INFECTION 37 0.0003
559 BRAIN FOG 4 0.0003
560 OEDEMA PERIPHERAL 31 0.0003
561 DIVERTICULITIS 7 0.0003
562 BLOOD ALBUMIN DECREASED 2 0.0003
563 ATRIAL FLUTTER 2 0.0003
564 VISUAL IMPAIRMENT 31 0.0002
565 DIABETIC KETOACIDOSIS 6 0.0002
566 HEPATITIS C 3 0.0002
567 RHINITIS 2 0.0002
568 LIVER DISORDER 11 0.0002
569 MYASTHENIA GRAVIS 2 0.0002
570 FIBROMYALGIA 6 0.0002
571 PERIPHERAL SWELLING 38 0.0002
572 RESTLESSNESS 9 0.0002
573 SHOCK HAEMORRHAGIC 2 0.0002
574 DECUBITUS ULCER 2 0.0002
575 CYTOPENIA 3 0.0002
576 ASPHYXIA 2 0.0002
577 SMALL INTESTINAL OBSTRUCTION 3 0.0002
578 HICCUPS 2 0.0002
579 ARTHRITIS BACTERIAL 1 0.0002
580 ESCHERICHIA INFECTION 2 0.0002
581 TOXICITY TO VARIOUS AGENTS 41 0.0002
582 ANAPHYLACTOID REACTION 1 0.0002
583 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
584 ANXIETY 69 0.0002
585 PHOTOSENSITIVITY REACTION 4 0.0002
586 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
587 MENSTRUAL DISORDER 2 0.0002
588 MEMORY IMPAIRMENT 33 0.0002
589 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
590 HAEMOGLOBIN DECREASED 24 0.0002
591 BLOOD POTASSIUM DECREASED 7 0.0002
592 ABNORMAL SENSATION IN EYE 1 0.0002
593 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
594 DRY SKIN 31 0.0002
595 SKIN ULCER 6 0.0002
596 OXYGEN SATURATION DECREASED 13 0.0002
597 PLASMA CELL MYELOMA 9 0.0002
598 CONDITION AGGRAVATED 70 0.0002
599 MUCOSAL INFLAMMATION 6 0.0002
600 URINE OUTPUT DECREASED 2 0.0002
601 SOMNOLENCE 46 0.0002
602 HYPERKALAEMIA 8 0.0002
603 PULMONARY CONGESTION 3 0.0002
604 IMMUNOSUPPRESSION 2 0.0002
605 ABDOMINAL ABSCESS 1 0.0002
606 BLOOD PRESSURE DECREASED 15 0.0002
607 BRAIN NEOPLASM MALIGNANT 1 0.0002
608 THROMBOSIS 18 0.0002
609 DRUG-INDUCED LIVER INJURY 7 0.0002
610 RASH PAPULAR 5 0.0002
611 MYOSITIS 2 0.0002
612 PANCREATITIS ACUTE 5 0.0002
613 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
614 ANAL INCONTINENCE 2 0.0002
615 BLOOD BILIRUBIN INCREASED 6 0.0002
616 EXOSTOSIS 2 0.0002
617 SHOCK 5 0.0002
618 LACTIC ACIDOSIS 7 0.0002
619 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
620 WOUND 6 0.0002
621 BACTERIAL INFECTION 4 0.0002
622 HEPATIC ENCEPHALOPATHY 2 0.0002
623 APPENDICITIS 2 0.0002
624 ALOPECIA 42 0.0002
625 ABDOMINAL PAIN UPPER 44 0.0002
626 PALPITATIONS 25 0.0002
627 FLANK PAIN 2 0.0002
628 SKIN REACTION 3 0.0002
629 INTESTINAL OBSTRUCTION 8 0.0002
630 BLOOD PROLACTIN INCREASED 1 0.0002
631 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
632 SINUS TACHYCARDIA 3 0.0002
633 CHEST PAIN 39 0.0002
634 HAEMATOTOXICITY 2 0.0002
635 FALL 70 0.0002
636 MOBILITY DECREASED 15 0.0002
637 PANCREATIC CARCINOMA 6 0.0002
638 MALAISE 91 0.0002
639 MYOCARDIAL INFARCTION 36 0.0002
640 DIZZINESS POSTURAL 2 0.0002
641 ATRIAL FIBRILLATION 20 0.0002
642 HAEMATURIA 7 0.0002
643 THERAPY CHANGE 2 0.0002
644 OFF LABEL USE 178 0.0002
645 HOSPICE CARE 2 0.0002
646 ABDOMINAL PAIN 47 0.0002
647 HAEMATOCRIT DECREASED 4 0.0002
648 UPPER LIMB FRACTURE 4 0.0002
649 PRESCRIBED UNDERDOSE 4 0.0002
650 URINARY TRACT INFECTION 34 0.0002
651 INSOMNIA 53 0.0002
652 TOXIC SKIN ERUPTION 2 0.0002
653 FULL BLOOD COUNT DECREASED 4 0.0002
654 EMPHYSEMA 2 0.0002
655 OSTEOPENIA 3 0.0002
656 ABDOMINAL DISCOMFORT 33 0.0002
657 DRUG LEVEL DECREASED 2 0.0002
658 MOTOR DYSFUNCTION 2 0.0002
659 INITIAL INSOMNIA 2 0.0002
660 DEVICE RELATED INFECTION 3 0.0002
661 FEMUR FRACTURE 6 0.0002
662 PERITONITIS 4 0.0002
663 EJECTION FRACTION DECREASED 3 0.0002
664 HEADACHE 121 0.0002
665 VENTRICULAR EXTRASYSTOLES 2 0.0002
666 ACUTE MYELOID LEUKAEMIA 3 0.0002
667 THERAPY PARTIAL RESPONDER 3 0.0002
668 PAIN 118 0.0002
669 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
670 WEIGHT FLUCTUATION 2 0.0002
671 PRODUCT USE COMPLAINT 3 0.0002
672 PAIN IN EXTREMITY 56 0.0002
673 BLOOD LACTIC ACID INCREASED 1 0.0002
674 INCONTINENCE 2 0.0002
675 SUDDEN DEATH 2 0.0002
676 HALLUCINATION, AUDITORY 3 0.0002
677 ABSCESS 3 0.0002
678 JOINT INJURY 4 0.0002
679 BREAST CANCER METASTATIC 2 0.0002
680 BLOOD GLUCOSE INCREASED 35 0.0002
681 DECREASED ACTIVITY 2 0.0002
682 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
683 PULMONARY THROMBOSIS 2 0.0002
684 VOMITING 86 0.0002
685 WOUND INFECTION 2 0.0002
686 MELAENA 4 0.0002
687 AUTISM SPECTRUM DISORDER 1 0.0002
688 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
689 HAEMATOCHEZIA 10 0.0002
690 COAGULOPATHY 3 0.0002
691 SKIN DISORDER 6 0.0002
692 ANGIOPATHY 1 0.0002
693 DIARRHOEA 115 0.0002
694 CHROMATURIA 4 0.0002
695 MITRAL VALVE INCOMPETENCE 2 0.0002
696 MYOCARDITIS 2 0.0002
697 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
698 BLOOD URIC ACID INCREASED 1 0.0002
699 LIVER FUNCTION TEST ABNORMAL 5 0.0002
700 COUGH 48 0.0002
701 FATIGUE 133 0.0002
702 HYPOTENSION 34 0.0002
703 MUSCLE RIGIDITY 2 0.0002
704 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
705 THYROID CANCER 2 0.0002
706 OSTEOMYELITIS 3 0.0002
707 LOCALISED INFECTION 4 0.0002
708 HYPERGLYCAEMIA 6 0.0002
709 TREATMENT NONCOMPLIANCE 9 0.0002
710 END STAGE RENAL DISEASE 3 0.0002
711 RECTAL HAEMORRHAGE 7 0.0002
712 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
713 BLOOD SODIUM DECREASED 3 0.0002
714 DERMATITIS ALLERGIC 2 0.0002
715 FRACTURE 3 0.0002
716 HEAD INJURY 5 0.0002
717 PROTEINURIA 3 0.0002
718 BLOOD PRESSURE INCREASED 24 0.0002
719 METABOLIC ACIDOSIS 5 0.0002
720 HEPATITIS 4 0.0002
721 PULMONARY OEDEMA 7 0.0002
722 SLEEP DISORDER 11 0.0002
723 CONTUSION 15 0.0002
724 ANAPHYLACTIC SHOCK 4 0.0002
725 CHOKING 3 0.0002
726 ORAL HERPES 3 0.0002
727 RESPIRATORY TRACT INFECTION 4 0.0002
728 ASPERGILLUS INFECTION 1 0.0002
729 ORAL CANDIDIASIS 2 0.0002
730 TOOTH INFECTION 2 0.0002
731 NAUSEA 119 0.0002
732 RENAL DISORDER 7 0.0002
733 JOINT RANGE OF MOTION DECREASED 2 0.0001
734 FREQUENT BOWEL MOVEMENTS 4 0.0001
735 OEDEMA 8 0.0001
736 BODY TEMPERATURE INCREASED 3 0.0001
737 IMPAIRED GASTRIC EMPTYING 2 0.0001
738 FEELING ABNORMAL 35 0.0001
739 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
740 MENTAL STATUS CHANGES 4 0.0001
741 PULMONARY HYPERTENSION 3 0.0001
742 AUTOIMMUNE HEPATITIS 1 0.0001
743 ABDOMINAL DISTENSION 15 0.0001
744 HYPOMAGNESAEMIA 2 0.0001
745 PRURITUS 55 0.0001
746 WITHDRAWAL SYNDROME 6 0.0001
747 SKIN EXFOLIATION 12 0.0001
748 DEVICE OCCLUSION 2 0.0001
749 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
750 PAIN IN JAW 4 0.0001
751 EATING DISORDER 3 0.0001
752 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
753 PARALYSIS 2 0.0001
754 ANGINA PECTORIS 4 0.0001
755 ARTHRALGIA 58 0.0001
756 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
757 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
758 APATHY 2 0.0001
759 GASTROENTERITIS 2 0.0001
760 DYSURIA 5 0.0001
761 LABORATORY TEST ABNORMAL 4 0.0001
762 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
763 HAEMORRHAGE INTRACRANIAL 2 0.0001
764 PANCREATITIS 7 0.0001
765 DIABETES MELLITUS 10 0.0001
766 EPILEPSY 4 0.0001
767 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
768 THYROID DISORDER 2 0.0001
769 LYMPHOMA 2 0.0001
770 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
771 DELUSION 2 0.0001
772 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
773 DIZZINESS 64 0.0001
774 NERVOUS SYSTEM DISORDER 4 0.0001
775 BALANCE DISORDER 11 0.0001
776 RESPIRATORY TRACT CONGESTION 2 0.0001
777 SCIATICA 2 0.0001
778 PANCYTOPENIA 7 0.0001
779 NASOPHARYNGITIS 23 0.0001
780 SENSORY DISTURBANCE 2 0.0001
781 MENTAL IMPAIRMENT 3 0.0001
782 MUSCLE TIGHTNESS 2 0.0001
783 RESPIRATORY FAILURE 9 0.0001
784 NEURALGIA 3 0.0001
785 BLOOD POTASSIUM INCREASED 2 0.0001
786 LETHARGY 7 0.0001
787 OSTEOPOROSIS 5 0.0001
788 CARDIAC ARREST 10 0.0001
789 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
790 ACUTE CORONARY SYNDROME 1 0.0001
791 CARDIO-RESPIRATORY ARREST 5 0.0001
792 NASAL CONGESTION 7 0.0001
793 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
794 FACE OEDEMA 2 0.0001
795 HAEMATEMESIS 3 0.0001
796 HEMIPARESIS 2 0.0001
797 NEUTROPENIA 16 0.0001
798 CIRCULATORY COLLAPSE 2 0.0001
799 PARANOIA 2 0.0001
800 NEOPLASM PROGRESSION 4 0.0001
801 ECZEMA 6 0.0001
802 MUSCULOSKELETAL STIFFNESS 10 0.0001
803 GASTRITIS 3 0.0001
804 HEART RATE DECREASED 4 0.0001
805 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
806 HEAD DISCOMFORT 2 0.0001
807 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
808 CEREBRAL HAEMORRHAGE 4 0.0001
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
810 DRY MOUTH 9 0.0001
811 GASTROENTERITIS VIRAL 2 0.0001
812 LEUKOCYTOSIS 2 0.0001
813 TOOTHACHE 2 0.0001
814 LIMB INJURY 3 0.0001
815 DISEASE PROGRESSION 13 0.0001
816 BRAIN NEOPLASM 1 0.0001
817 ANAPHYLACTIC REACTION 6 0.0001
818 PROCEDURAL PAIN 3 0.0001
819 BRONCHITIS 8 0.0001
820 INFLUENZA 12 0.0001
821 DYSPNOEA EXERTIONAL 4 0.0001
822 FOOT FRACTURE 2 0.0001
823 NEUROPATHY PERIPHERAL 10 0.0001
824 INCREASED APPETITE 2 0.0001
825 LOWER LIMB FRACTURE 2 0.0001
826 SEIZURE 12 0.0001
827 WEIGHT DECREASED 29 0.0001
828 GLAUCOMA 2 0.0001
829 ATELECTASIS 1 0.0001
830 NEEDLE ISSUE 3 0.0001
831 EAR PAIN 2 0.0001
832 PSYCHOTIC DISORDER 3 0.0001
833 LOSS OF CONSCIOUSNESS 13 0.0001
834 URINARY INCONTINENCE 3 0.0001
835 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
836 RESPIRATORY DISORDER 3 0.0001
837 AGGRESSION 5 0.0001
838 APHASIA 3 0.0001
839 CONFUSIONAL STATE 16 0.0001
840 SUICIDE ATTEMPT 6 0.0001
841 TASTE DISORDER 2 0.0001
842 DYSKINESIA 4 0.0001
843 PRODUCT PREPARATION ERROR 2 0.0001
844 LUNG NEOPLASM MALIGNANT 4 0.0001
845 RIB FRACTURE 2 0.0001
846 RHABDOMYOLYSIS 4 0.0001
847 SPEECH DISORDER 5 0.0001
848 BREAST PAIN 1 0.0001
849 HIP FRACTURE 3 0.0001
850 IRRITABLE BOWEL SYNDROME 2 0.0001
851 FAECES DISCOLOURED 2 0.0001
852 CHRONIC KIDNEY DISEASE 7 0.0001
853 BACK INJURY 1 0.0001
854 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
855 BLOOD GLUCOSE FLUCTUATION 1 0.0001
856 TREMOR 15 0.0001
857 SYNCOPE 9 0.0001
858 TOOTH DISORDER 2 0.0001
859 RASH MACULO-PAPULAR 2 0.0001
860 HEPATOTOXICITY 2 0.0001
861 GAIT INABILITY 3 0.0001
862 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
863 COLITIS ULCERATIVE 4 0.0001
864 BLISTER 5 0.0001
865 THERAPY NON-RESPONDER 4 0.0001
866 PRODUCT AVAILABILITY ISSUE 2 0.0001
867 NEPHROLITHIASIS 4 0.0001
868 DEATH 75 0.0001
869 ASTHENIA 32 0.0001
870 PRODUCT DOSE OMISSION ISSUE 25 0.0001
871 LYMPHADENOPATHY 3 0.0001
872 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
873 ACCIDENT 1 0.0001
874 ENCEPHALOPATHY 2 0.0001
875 EPISTAXIS 6 0.0001
876 DYSARTHRIA 3 0.0001
877 HOT FLUSH 6 0.0001
878 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
879 ABDOMINAL PAIN LOWER 2 0.0001
880 GASTRIC CANCER 2 0.0001
881 CARDIOVASCULAR DISORDER 2 0.0001
882 HOSPITALISATION 12 0.0001
883 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
884 INFLAMMATION 4 0.0001
885 UNRESPONSIVE TO STIMULI 2 0.0001
886 HAEMORRHAGE 8 0.0001
887 BEDRIDDEN 1 0.0001
888 DISORIENTATION 3 0.0001
889 RENAL FAILURE 10 0.0001
890 PROSTATE CANCER 6 0.0001
891 JAUNDICE 2 0.0001
892 DEVICE BREAKAGE 3 0.0001
893 PALLOR 2 0.0001
894 AKATHISIA 1 0.0001
895 ACUTE HEPATIC FAILURE 1 0.0001
896 RESPIRATORY ARREST 2 0.0001
897 ARTHROPATHY 4 0.0001
898 FEELING COLD 2 0.0001
899 OSTEOARTHRITIS 3 0.0001
900 FLATULENCE 4 0.0001
901 INTENTIONAL DOSE OMISSION 2 0.0001
902 BRONCHOSPASM 1 0.0001
903 CARDIOGENIC SHOCK 1 0.0001
904 HYPOACUSIS 3 0.0001
905 DYSSTASIA 2 0.0001
906 SINUSITIS 7 0.0001
907 DRUG INEFFECTIVE 89 0.0001
908 WEIGHT INCREASED 15 0.0001
909 DEPRESSION 15 0.0001
910 URTICARIA 11 0.0001
911 DISCOMFORT 4 0.0001
912 INTENTIONAL OVERDOSE 4 0.0001
913 MOVEMENT DISORDER 2 0.0001
914 DEEP VEIN THROMBOSIS 4 0.0001
915 BACK DISORDER 1 0.0001
916 SWELLING FACE 4 0.0001
917 EYE DISORDER 2 0.0001
918 VISUAL ACUITY REDUCED 2 0.0001
919 TYPE 2 DIABETES MELLITUS 2 0.0001
920 CANDIDA INFECTION 1 0.0001
921 ANGER 2 0.0001
922 CHEST DISCOMFORT 6 0.0001
923 VISION BLURRED 8 0.0001
924 GAIT DISTURBANCE 11 0.0001
925 AMENORRHOEA 1 0.0001
926 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
927 BRADYCARDIA 3 0.0001
928 THERAPY INTERRUPTED 4 0.0001
929 ADVERSE DRUG REACTION 5 0.0001
930 PANIC ATTACK 2 0.0001
931 SUICIDAL IDEATION 5 0.0001
932 AGRANULOCYTOSIS 1 0.0001
933 CARDIAC DISORDER 5 0.0001
934 CEREBROVASCULAR ACCIDENT 9 0.0001
935 BLOOD URINE PRESENT 1 0.0001
936 DYSPEPSIA 5 0.0001
937 ABNORMAL BEHAVIOUR 2 0.0001
938 CATARACT 3 0.0001
939 EXTRA DOSE ADMINISTERED 2 0.0000
940 BONE MARROW FAILURE 1 0.0000
941 FEELING HOT 3 0.0000
942 HYPOAESTHESIA 7 0.0000
943 DEVICE LEAKAGE 2 0.0000
944 DEVICE DISLOCATION 2 0.0000
945 MENTAL DISORDER 2 0.0000
946 PRODUCT STORAGE ERROR 4 0.0000
947 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
948 GASTROINTESTINAL DISORDER 4 0.0000
949 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
951 SKIN DISCOLOURATION 2 0.0000
952 BLOOD CHOLESTEROL INCREASED 2 0.0000
953 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
954 BLOOD GLUCOSE DECREASED 2 0.0000
955 AGITATION 3 0.0000
956 DYSGEUSIA 3 0.0000
957 AGEUSIA 1 0.0000
958 THERAPY CESSATION 2 0.0000
959 ILLNESS 4 0.0000
960 MUSCULOSKELETAL PAIN 2 0.0000
961 DEPRESSED MOOD 2 0.0000
962 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
963 RASH PRURITIC 2 0.0000
964 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
965 ABNORMAL DREAMS 1 0.0000
966 NECK PAIN 2 0.0000
967 MYALGIA 6 0.0000
968 EYE IRRITATION 2 0.0000
969 DYSPHONIA 2 0.0000
970 ILL-DEFINED DISORDER 2 0.0000
971 VERTIGO 2 0.0000
972 MUSCLE SPASMS 6 0.0000
973 ADVERSE EVENT 3 0.0000
974 OROPHARYNGEAL PAIN 3 0.0000
975 INJECTION SITE ERYTHEMA 4 0.0000
976 BONE DENSITY DECREASED 1 0.0000
977 INJURY 2 0.0000
978 INJECTION SITE SWELLING 2 0.0000
979 CHILLS 3 0.0000
980 ABORTION SPONTANEOUS 1 0.0000
981 DRUG WITHDRAWAL SYNDROME 2 0.0000
982 NO ADVERSE EVENT 4 0.0000
983 BREAST CANCER 2 0.0000
984 ARRHYTHMIA 1 0.0000
985 INJECTION SITE PAIN 6 0.0000
986 PARAESTHESIA 3 0.0000
987 INCORRECT DOSE ADMINISTERED 4 0.0000
988 BONE PAIN 1 0.0000
989 EMOTIONAL DISTRESS 2 0.0000
990 DRUG DEPENDENCE 2 0.0000